These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 9521326)

  • 1. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tailless fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice.
    Kabra NH; Cado D; Winoto A
    J Immunol; 1999 Mar; 162(5):2766-74. PubMed ID: 10072523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced basal AP-1 activity and de-regulation of numerous genes in T cells transgenic for a dominant interfering mutant of FADD/MORT1.
    Chaneva S; Schneider G; Siegmund D; Wajant H; Mages J; Häcker G
    Eur J Immunol; 2004 Nov; 34(11):3006-15. PubMed ID: 15376191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for Daxx in mature T-cell proliferation and activation.
    Leal-Sanchez J; Couzinet A; Rossin A; Abdel-Sater F; Chakrabandhu K; Luci C; Anjuere F; Stebe E; Hancock D; Hueber AO
    Cell Death Differ; 2007 Apr; 14(4):795-806. PubMed ID: 17082815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells.
    Mack A; Häcker G
    Eur J Immunol; 2002 Jul; 32(7):1986-92. PubMed ID: 12115619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes.
    O'Reilly LA; Divisekera U; Newton K; Scalzo K; Kataoka T; Puthalakath H; Ito M; Huang DC; Strasser A
    Cell Death Differ; 2004 Jul; 11(7):724-36. PubMed ID: 15017386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells.
    Lens SM; den Drijver BF; Pötgens AJ; Tesselaar K; van Oers MH; van Lier RA
    J Immunol; 1998 Jun; 160(12):6083-92. PubMed ID: 9637525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins.
    Memon SA; Hou J; Moreno MB; Zacharchuk CM
    J Immunol; 1998 Mar; 160(5):2046-9. PubMed ID: 9498739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant negative MORT1/FADD rescues mice from CD95 and TNF-induced liver failure.
    Schuchmann M; Varfolomeev EE; Hermann F; Rueckert F; Strand D; Koehler H; Strand S; Lohse AW; Wallach D; Galle PR
    Hepatology; 2003 Jan; 37(1):129-35. PubMed ID: 12500197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
    Gil J; Esteban M
    Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis.
    Hershberger PA; He H; McCarthy SA
    Cell Immunol; 1998 May; 185(2):134-45. PubMed ID: 9636691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL.
    Alcouffe J; Therville N; Ségui B; Nazzal D; Blaes N; Salvayre R; Thomsen M; Benoist H
    FASEB J; 2004 Jan; 18(1):122-4. PubMed ID: 14630709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Fas pathway independently of Fas ligand during apoptosis induced by camptothecin in p53 mutant human colon carcinoma cells.
    Shao RG; Cao CX; Nieves-Neira W; Dimanche-Boitrel MT; Solary E; Pommier Y
    Oncogene; 2001 Apr; 20(15):1852-9. PubMed ID: 11313933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
    Newton K; Harris AW; Bath ML; Smith KG; Strasser A
    EMBO J; 1998 Feb; 17(3):706-18. PubMed ID: 9450996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a dominant negative form of Daxx in vivo rescues motoneurons from Fas (CD95)-induced cell death.
    Raoul C; Barthelemy C; Couzinet A; Hancock D; Pettmann B; Hueber AO
    J Neurobiol; 2005 Feb; 62(2):178-88. PubMed ID: 15459896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FADD is required for multiple signaling events downstream of the receptor Fas.
    Juo P; Woo MS; Kuo CJ; Signorelli P; Biemann HP; Hannun YA; Blenis J
    Cell Growth Differ; 1999 Dec; 10(12):797-804. PubMed ID: 10616904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor.
    Newton K; Harris AW; Strasser A
    EMBO J; 2000 Mar; 19(5):931-41. PubMed ID: 10698935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.